Non-compliant medical devices: what are the risks?

Published 
December 14, 2020

Risks in the event of non-compliance of your medical devices

The new medical devices regulation aims to improve market transparency in Europe, product traceability, and consumer safety. Having a non-compliant device on the market exposes you to many risks.

A financial loss

In particular, the financial loss related to non-compliance is consequential. Potential financial penalties from the authorities have to be taken into account here, but not only! The recall of a product, for example, can lead to significant costs. Finally, lawsuits may be initiated by consumers: the expenses linked to this type of incident are substantial.

Risks related to brand image

Your company's image can quickly be affected by a non-compliant MD. The press quickly grasps this type of subject, and the emergence of numerous consumer associations enables consumers to exchange information more easily and quickly. All this is, of course, facilitated by digital tools and their multiplication in recent years.

Sanctions by Member States

The Member States of the European Union have until 21st February 2021 to notify the European Commission of the penalties and sanctions they will apply in the event of non-compliance with Regulation 2017/745. These sanctions may be financial penalties or even product withdrawals or recalls. We will come back to you towards the end of February with the specific elements.

MDR: evolving obligations

Economic operators under Regulation 2017/745 on medical devices have many obligations. To avoid ending up with a non-compliant device, you should, among other things, make sure that:

  • the device is designed, manufactured and produced in accordance with the requirements and the QMS (Quality Management System)
  • the device and the economic operator are registered on EUDAMED
  • the CE marking and the attribution of the UDI (Unique Device Identifier) are compliant
  • etc.

To find out in detail your requirements, we invite you to watch the replay of our webinar. EcoMundo can assist you in bringing your devices into compliance on the European market.

Wish to know more about medical devices?

For more information, do not hesitate to contact Raïssa Abdel Kader or one of our experts!

Contact us

Related articles

vignette blog

Regulation 2017/745 on MDs: what are the major changes?

Regulation 2017/745 on medical devices will enter into force on 26th May 2021. After having seen its first...Read more

vignette blog

Covid-19: the medical devices regulation deadline postponed to 2021

The European Commission voted mid-April to postpone the implementation of the regulation on medical...Read more

vignette blog

5 questions on... the new european medical devices regulation

Although its application has been postponed for one year, the new medical devices regulation implies...Read more

Encore +

Articles similaires

Tous
Cosmetics
7
/
23
/
2024

Global PFAS Regulations: Impact on the Cosmetic Industry

PFAS (per- and polyfluoroalkyl substances) are a class of human-made chemicals used extensively since the 1950s due to their non-stick, water-repellent, and grease-resistant properties. Found in products ranging from cookware to firefighting foams and cosmetics, PFAS have recently been scrutinized for their persistence in the environment and potential health hazards, prompting new regulations across the globe.
Food Supplements
7
/
16
/
2024

Compl'Alim: How to Declare My Dietary Supplements in France? Teleicare Becomes Compl'Alim

Compl'Alim is a state-owned start-up sponsored by the DGAL, designed to replace the obsolete Teleicare system. Its aim is to improve the regulatory and notification process for food supplements, guaranteeing greater safety and transparency. By modernising the process, Compl'Alim improves the transparency and accessibility of data for professionals and consumers, with the aim of being fully operational by September 2024.
Cosmetics
7
/
11
/
2024

Global Regulations of Secondary Sunscreens: A Comparative Overview

Regulating sunscreen products has always been challenging, given their impact on consumers and their health. From a regulatory standpoint, a product's primary function determines the conditions it must meet to be placed on the market. As UV protection has become a standard, there is an abundance of cosmetic products displaying a Sun Protection Factor (SPF) on the market.